Anesthesia and Perioperative Care in the Cytoreductive Surgery and HIPEC

Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is a major surgical procedure that is being used increasingly frequently in therapeutic option for selected patients with peritoneal surface malignancies. This is more blood and fluid shift and coagulation changes could be seen in cytoreductive surgery phase. It is applied before hyperthermic intraperitoneal chemotherapy phase and process is longer than hyperthermic intraperitoneal chemotherapy phase. Significant hematologic, hemodynamic and metabolic changes have been seen is in hyperthermic intraperitoneal chemotherapy phase. This surgical procedure is quite a difficult process of anesthetists. The task of anesthesiologist is to know during pathophysiological changes occurring in each phase and accordingly take measures in perioperative. These patients require close monitoring of intraoperative and postoperative period. Primary disease as well as the size of the surgical area, anesthetic administration and the amount of fluid and blood transfusion may affect the outcome. There is a need for further work on this issue. There is no consensus gradually formed on anesthesia despite the increasing frequency. In this article, perioperative anesthetic management are described in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy.

PDF

___

Elias D, Honore C, Ciuchendea R, Elias D, Honoré C, Ciuchendéa R,,.et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008;95:1164 –71.
Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458–63.
Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27:681–5.
Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010;28:63–8.
Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, et al; Society of Surgical Oncology Annual Meeting. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 2007;14:128-33.
Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al.ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary—a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Anesth Analg 2008;106:685-12.
Cafiero T, Di Iorio C, Di Minno RM, Sivolella G, Confuorto G. Noninvasive cardiac monitoring by aortic blood flow determination in patients undergoing hyperthermic intraperitoneal intraoperative chemotherapy. Minerva Anestesiol 2006; 72:207–15.
Kellum JA, Decker JM. Use of dopamine in acute renal failure: a metaanalysis. Crit Care Med 2001; 29:1526–31.
Karthik S, Lisbon A. Low-dose dopamine in the intensive care unit. Semin Dialysis 2006; 19:465–71.
Kusamura S, Baratti D, Younan R, Laterza B, Oliva GD, Costanzo P, et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 2007;14:2550-8
Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723–40.
Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med 1990; 18:728–33.
Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL . A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008;12:R74.
Kajdi ME, Beck-Schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol 2014 May 1;12:136
Rehm M, Zahler S, Lötsch M, Welsch U, Conzen P, Jacob M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albümin solutions in the coronary vascular bed. Anesthesiology 2004; 100:1211–23.
Shime N, Lee M, Hatanaka T. Cardiovascular changes during continuous hyperthermic peritoneal perfusion. Anesth Analg 1994; 78:938–42.
Esquivel J, Angulo F, Bland RK, Stephens AD, Sugarbaker PH. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open ‘coliseum technique’. Ann Surg Oncol 2000; 7:296–300.
Schmidt C, Creutzenberg M, Piso P, Hobbhahn J, Bucher M. Perioperative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia 2008;63:389-95.
Bickel A, Arzomanov T, Ivry S, Zveibl F, Eitan A. Reversal of adverse hemodynamic effects of pneumoperitoneum by pressure equilibration. Arch Surg 2004; 139:1320–5.
Mertens zur Borg IR, Lim A, Verbrugge SJ, IJzermans JN, Klein J. Effect of intraabdominal pressure elevation and positioning on hemodynamic responses during carbon dioxide pneumoperitoneum for laparoscopic donor nephrectomy:a prospective controlled clinical study. Surg Endosc 2004; 18:919–23.
Rueth NM, Murray SE, Huddleston SJ, Abbott AM, Greeno EW, Kristein MN, et al. Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C. Ann Surg Oncol 2011;18:174- 80.
Thix CA, Königsrainer I, Kind R, Wied P, Schroeder TH. Ventricular tachycardia during hyperthermic intraperitoneal chemotherapy. Anaesthesia 2009; 64:1134–6.
Michelson AD, MacGregor H, Barnard MR, Kestin AS, Rohrer MJ, Valeri CR. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 1994; 71:633–40.
Kanakoudis F, Petrou A, Michaloudis D, Chortaria G, Konstantinidou A. Anaesthesia for intra peritoneal perfusion of hyperthermic chemotherapy. Haemodynamic changes, oxygen consumption and delivery. Anaesthesia 1996;51:1033-6.
Kamal JM, Elshaikh S M, Nabil D, Mohamad MA. The perioperative course and anesthetic challenge for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Egyptian J Anaesthesia 2013;29:311-8.
Caldwell JE, Heier T, Wright PMC, Lin S, McCarthy G, Szenohradszky J, et al.Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology 2000;92:84–93.
Flynn PJ, Hughes R, Walton B, Jothilingam S. Use of atracurium infusions for general surgical procedures including cardiac surgery with induced hypothermia. Br J Anaesth 1983;55:135–8S.
Jonker G, Hoogenboom LJ, van Ramshorst B, Bruins P. Atracurium during induced hyperthermia. J Anesth 2009;23(3):442-4.
Adachi T, Shinomura T, Nomura R.Duration of vecuronium induced neuromuscular blockade is shortened during hyperthermic intraoperative intraperitoneal chemotherapy. Br. J. Anaesth 2003;91:160-1
Saxena A, Yan TD, Chua TC, Fransi Sal, Almohaimeed K, Ahmed S, et al. Factors for massive blood transfusion in cytoreductive surgery: a multivariate analysis of 243 procedures. Ann Surg Oncol 2009;16:2195–203.
Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice? Curr Opin Anaesthesiol 2009,22:305–12.
Hansen E, Knuechel R, Altmeppen J, Taeger K. Blood irradiation forintraoperative autotransfusion in cancer surgery: demonstration of efficientelimination of contaminating tumor cells. Transfusion 1999; 39:608– 15.
Hansen E, Bechmann V, Altmeppen J. Intraoperative blood salvage with irradiation of blood in cancer surgery: answers to current queries. Anasthesiol Intensivmed Notfallmed Schmerzther 2002; 37:740–4.
Arakelian E, Gunningberg L, Larsson J, Norlén K, Mahteme H. Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2011; 37:897– 03.
Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O et al. Cytoreductive surgery and hyperthermicintraperitoneal chemotherapy for malignant peritoneal mesothelioma:multiinstitutional experience. J Clin Oncol 2009; 27:6237–42.
Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial:cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectalcancer. Ann Surg Oncol 2008; 15:2426–32.
Dixon E, Datta I, Sutherland FR, Vauthey JN. Blood loss in surgical oncology: neglected quality indicator? J Surg Oncol 2009, 99:508–12.
Cooksley TJ, Haji-Michael P. Postoperative critical care management of patients undergoing cytoreductive surgery and Heated Intraperitoneal Chemotherapy (HIPEC). World J Surg Oncol 2011; 9:169.
Baratti D, Kusamura S, Laterza B, Balestra M, Deraco M. Early and longterm postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Gastrointest Oncol 2010;2(1):36–3.
Miao N, Pingpank JF, Alexander HR, Royal R, Steinberg SM, Quezado MM, et al. Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations. Ann Surg Oncol 2009;16(2):334–44.
Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003;10:863–9.
Zielmann S, Grote R. The effects of long-term sedation on intestinal function.Anaesthesist 1995; 44 (Suppl 3):549–58.
Blumenthal S, Min K, Nadig M, Borgeat A. Double epidural catheter with ropivacaineversus intravenous morphine: a comparison for postoperative analgesia after scoliosis correction surgery. Anesthsiology 2005; 102:175–80.
Wulf H. Epidural anaesthesia and spinal haematoma. Can J Anaesth 1996;43:1260–71.